Unveiling potential adverse events associated with escitalopram oxalate: A real-world analysis based FDA adverse event reporting system database.
Ying JiangYusi ChengZhiqiang DuYuan ShenQin ZhouYingying JiHaohao ZhuPublished in: Journal of psychopharmacology (Oxford, England) (2024)
While escitalopram oxalate has clear benefits in the treatment of depression and other mental health disorders, the presence of AEs also suggests risks associated with its use. Particularly concerning are risks of suicide and changes in serum serotonin levels.